Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-25 @ 9:19 PM
Study NCT ID:
NCT07180056
Status:
RECRUITING
Last Update Posted:
2025-11-19
First Post:
2025-09-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
Sponsor:
Wenjin Yin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-11
First Submit QC Date:
None
Study First Post Date:
2025-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-16
Last Update Post Date:
2025-11-19
Last Update Post Date Type:
ESTIMATED